Insiders · ABVC

Eugene Jiang

Officer, Director at Abvc Biopharma, Inc. (ABVC) since August 2021

Eugene Jiang has filed 1 insider report with the SEC since November 2021, as officer and director at Abvc Biopharma, Inc. (ABVC). The latest filing, on November 15, 2021, is a Form 3: Eugene Jiang became an insider at Abvc Biopharma, Inc. (ABVC).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Eugene Jiang is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Abvc Biopharma, Inc. logo
ABVC
Abvc Biopharma, Inc.
Officer, Directorsince August 2021$0.94Nov 15, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Questions about Eugene Jiang

What is Eugene Jiang's role at Abvc Biopharma, Inc.?
Eugene Jiang reports to the SEC as officer and director at Abvc Biopharma, Inc. (ABVC), according to the latest filing on November 15, 2021.
Has Eugene Jiang bought or sold stock recently?
No open-market purchases or sales by Eugene Jiang are on file.
How do I get alerts when Eugene Jiang files?
Follow Eugene Jiang on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eugene Jiang (SEC CIK 0001892728). Totals count each trade once, skipping amendments whose original is on file, from Nov 15, 2021 on. View on SEC EDGAR